Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-1 receptor

1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-1 receptor

US Patent 8741916 · Granted Jun 3, 2014

Estimated economic value: $68,910,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclic dinucleotides as sting agonists2023
Cyclic dinucleotides as sting agonists2022
Cyclic dinucleotides as sting agonists2022
Cyclic dinucleotides as sting agonists2021
Substituted thiohydantoin derivatives as androgen receptor antagonists2021
Substituted thiohydantoin derivatives as androgen receptor antagonists2019
Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cance2018
Substituted thiohydantoin derivatives as androgen receptor antagonists2018
Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-2014
Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful f2014
Pyrimidine compounds as delta opioid receptor modulators2014
4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl pept2014